Certara is collaborating with NVIDIA to enhance its drug discovery capabilities using artificial intelligence. The partnership involves the use of NVIDIA's BioNeMo agent toolkit to accelerate the drug development process. The integration of AI agents is expected to strengthen Certara's platform for drug discovery and development.